Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Napier Park is Betting Big on Media General (MEG) and Allergan (AGN) for 2016; Plus 3 Other Major Moves

Based in New York, Napier Park Global Capital was spun out of Citi Capital Advisors in 2013 and is now overseeing approximately $6.2 billion worth of assets. The fund’s managers, Jim O’Brien and Jonathan Dorfman boast a modest equity portfolio, worth roughly $182 million at the end of 2015. They seem to have a knack for picking healthcare and consumer discretionary stocks, which account for roughly 70% of their portfolio. Napier Park was named 2015 Hedge Fund Manager of the Year by Risk magazine, in recognition for their expertise in “credit-intensive and structured assets.” In this article, we’ll take a look at some of the most eye-catching equity moves made by the firm during the fourth quarter, including in companies like Alphabet Inc (NASDAQ:GOOG) and Allergan plc Ordinary Shares (NYSE:AGN).

The smart money sentiment is an important metric that can be used to assess the long-term profitability of a stock. While there are thousands of stocks trading daily on the market, taking a look at what hedge funds think about certain companies can narrow down the search significantly. At Insider Monkey, we track more than 700 hedge funds, whose 13F filings we analyze as part of our small-cap strategy. Our research has shown that imitating a portfolio that includes the 15 most popular small-cap stocks among hedge funds can outperform the market by as much as 95 basis points per month on average (see more details here).

Jim O'brien And Jonathan Dorfman
Jim O'brien And Jonathan Dorfman
Napier Park Global Capital

At the end of the third quarter Allergan plc Ordinary Shares (NYSE:AGN) was the most popular stock among the funds followed by Insider Monkey and Napier Park likes it as well, having made it the third-largest bet of the firm as of the end of the fourth quarter. In the latest 13F filing, the fund indicated ownership of 28,975 shares, up by 28% over the quarter. According to the same filing, the position is worth a little over $9.05 million. Currently in a merger process with Pfizer Inc. (NYSE:PFE), Allergan plc Ordinary Shares (NYSE:AGN) was heavily courted by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in 2014, which offered as much as $53.3 billion for the company, but Allergan’s management rejected the proposed deal as being too risky. The company was then acquired by Actavis, another pharmaceutical company, for $66 billion, which decided to use Allergan’s name for the newly-formed entity. Less than a year after the merger, Pfizer came knocking, as the U.S drug manufacturer was looking for a deal that would help it change its fiscal domicile and take advantage of Ireland’s lower tax rates.

Follow Allergan Inc (NYSE:AGN)
Trade (NYSE:AGN) Now!

Humana Inc (NYSE:HUM) is a new addition to the equity portfolio of Napier Park. During the fourth quarter, O’Brien and Dorfman bought a total of 30,000 shares worth in excess of $5.35 million at the end of December. Although Humana Inc (NYSE:HUM) shares ended 2015 up by 23% for the year, it is important to note that the stock was up by 51% year-to-date at the end of May. Since then the stock has been in a downtrend, which has spilled over into 2016, with shares down by 9.3% this year. Humana Inc (NYSE:HUM) reported fourth quarter financial results yesterday, missing analysts’ estimates. Revenue came in at $13.36 billion, below the consensus of $13.48 billion, while earnings stood at $1.45 per share when adjusted for non-recurring costs, while analysts were looking for $1.46 per share.

Follow Humana Inc (NYSE:HUM)
Trade (NYSE:HUM) Now!

On to other sizable moves: O’Brien and Dorfman boosted their stake in Media General Inc (NYSE:MEG) by 64% during the quarter, taking it to 486,200 shares valued at approximately $7.85 million. The company is set to announce its fourth quarter results on February 26 and analysts are forecasting revenue of $372 million and earnings of $0.22 per share. Media General Inc (NYSE:MEG) has been in the middle of a merger soap opera as well recently, having agreed in September to acquire Meredith Corporation (NYSE:MDP) for $2.4 billion, only to end up selling itself to Nexstar Broadcasting Group, Inc. (NASDAQ:NXST) after an initial unsolicited offer of $14.50 per share that was later increased to $17.14 per share, valuing Media General Inc (NYSE:MEG) at $4.6 billion.

Follow Media General Inc (NYSE:NYSE: MEG)
Trade (NYSE:NYSE: MEG) Now!

Turn the page to find out the latest moves made in Napier’s holdings of Alphabet and PJT Partners.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...